As for clinical outcomes, in the T2DM group, there was a significant reduction in HbA1c (decreased by 1.01% to 1.02%, placebo-adjusted) and a clinically meaningful decrease in body weight of 3.26% to 3.51% after 12 weeks of treatment
Nanuka Tsibadze and colleagues at Jefferson Einstein Philadelphia conducted a nationwide retrospective analysis of 4,104 PsA patients on GLP-1s versus 86,432 PsA patients not on GLP-1s. The results: Mortality: 1.4% in the GLP-1 group vs
Because the scale is not the whole story
These medications include semaglutide (Ozempic, Wegovy) and dulaglutide (Trulicity) for both diabetes and weight management, and liraglutide (Victoza for diabetes, Saxenda for weight management)
Eli Lilly and Novo Nordisk both offer savings cards for eligible patients
(9) This and other hormonal disruptions from lack of sleep can also lead to an increased appetite and increased cravings for sugar, salt, or refined carbohydrates